Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ST-002 by SteroTherapeutics for Cushing's Syndrome: Likelihood of Approval
ST-002 is under clinical development by SteroTherapeutics and currently in Phase II for Cushing's Syndrome. According to GlobalData, Phase II...